Achondroplasia Latest Advances
Find the Latest Research About Achondroplasia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3525 publications
Infigratinib in Achondroplasia - A Potentially Giant Step Forward.
Journal: The New England journal of medicine
Published: September 02, 2026
Healthcare and Psychosocial Needs in Achondroplasia Across the Lifespan: Developmental Functioning, Multidisciplinary Care, and Family-Centered Outcomes.
Journal: Healthcare (Basel, Switzerland)
Published: July 22, 2026
From FGFR3 Hyperactivation to Disease-Modifying Therapy in Pediatric Achondroplasia: Molecular Mechanisms, Clinical Evidence, and Emerging Treatments.
Journal: Children (Basel, Switzerland)
Published: July 22, 2026
A new oral treatment for achondroplasia in children.
Journal: Nature reviews. Endocrinology
Published: July 14, 2026
Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia.
Journal: The New England journal of medicine
Published: June 29, 2026
Second drug approved for achondroplasia.
Journal: The American journal of nursing
Published: June 25, 2026
Slipped Capital Femoral Epiphysis during Vosoritide Therapy for Short Stature: A Case Series.
Journal: Hormone research in paediatrics
Published: June 14, 2026
Thanatophoric Dysplasia Type 1 with Severe Pulmonary Hypoplasia: Discharge after Tracheostomy.
Journal: Zeitschrift fur Geburtshilfe und Neonatologie
Published: June 10, 2026
Altered body composition in children and adolescents with achondroplasia.
Journal: Frontiers in nutrition
Published: May 29, 2026
Adverse health outcomes across the life course in individuals with six rare bone diseases: a 10-year population-based cohort study.
Journal: European journal of endocrinology
Published: May 23, 2026
Correction to: Efficacy and Safety of Oral Meclizine for Growth Promotion in Children with Achondroplasia: A Phase 2 Clinical Trial.
Journal: Calcified tissue international
Published: May 13, 2026
Last Updated: 09/26/2026